|  |  |  | Intervention group | Control group | Intervention vs. control group |  | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Study / Design | Methodological quality | Outcome domain | Selected outcome measure | Baseline Mean ± sd | Follow-up Mean ± sd | Within group mean difference | Within group SMD | Baseline Mean ± sd | Follow-up Mean ± sd | Between group difference in change from baseline | Between group SMD in change from baseline c | Narrative summary of findings on PIFM strength |
Taddei et al. [39] Randomized controlled trial | High | Foot and ankle biomechanics | MLA ROM (°) | 4.2 ± 2.4 | 3.6 ± 2.3 | −0.6 | 0.26 | 4.6 ± 2.2 | 4.6 ± 1.8 | −0.6 | 0.26 | MRI assessed PIFM volume was significantly increased in IG as opposed to CG, whereas CSA and toe plantar flexion strength remained unchanged |
 |  | Ground reaction forces | GRF vertical impulse in second half of stance (N·s) | 65.9 ± 7.9 | 67.9 ± 6.5 | 2.0 | 0.28NR | 74.3 ± 7.0 | 73.5 ± 6.5 | 2.8 | 0.37†|  |
Okamura et al. [40] Randomized controlled trial | High | Foot and ankle biomechanics | Navicular drop (mm) | 6.2 ± 1.7 | 6.2 ± 1.5 | 0.0 | 0.00 | 5.9 ± 2.6 | 5.4 ± 2.5 | 0.5 | − 0.23 | US assessed PIFM thickness in IG and CG remained unchanged |
 |  | Ground reaction forces | GRF vertical in second half of stance (% BW) | 109.1 ± 4.5 | 108.3 ± 5.7 | −0.8 | −0.16 | 107.5 ± 6.2 | 108.4 ± 6.5 | −1.7 | −0.31 |  |
 |  | Spatiotemporal parameters | Stance phase duration (ms) | 610.1 ± 36.8 | 600.4 ± 34.5 | −9.7 | 0.27 | 623.6 ± 36.8 | 618.8 ± 47.1 | −4.9 | 0.13 |  |
Matsumoto et al. [58] Pre-post intervention study | Low | Foot and ankle biomechanics | MLA compression (°) | 3.72 ± 6.8 | 3.65 ± 9.8 | −0.07 | 0.01 | n/a | n/a | n/a | n/a | Toe grip strength in IG was significantly increased |
 |  | Spatiotemporal parameters | Gait speed (m/s) | 0.33 ± 0.02 | 0.33 ± 0.04 | 0.00 | 0.00 | n/a | n/a | n/a | n/a |  |
Lynn et al. [53] Randomized controlled trial | High | Dynamic balance | YBT mediolateral CoP excursion for non-dominant stance leg (mm) | 52.4 ± 4.5 | 43.1 ± 5.1 | −9.3 | 1.83* | 47.8 ± 7.8 | 48.1 ± 5.5 | −9.6 | 1.43†| n/a |
Lee and Choi [54] Randomized controlled trial | Moderate | Dynamic balance | YBT composite reach distance (% leg length) | 66.8 ± 9.6 | 70.9 ± 8.7 | 6.1b | 0.66* | 65.4 ± 8.7 | 66.7 ± 9.1 | 3.8b | 0.41†| n/a |
Mulligan et al. [56] Pre-post intervention study | Moderate | Dynamic balance | SEBT reach distance in medial direction (cm) | 57.8 ± 7.4 | 61.6 ± 6.6 | 3.8 | 0.54* | n/a | n/a | n/a | n/a | n/a |
Tudpor et al. [55] Non-randomized controlled trial | Low | Dynamic balance | SEBT reach distance in the lateral direction (% leg length) | 54.8 ± 5.4a | 53.6 ± 9.6a | −1.2 | −0.15 | 59.0 ± 9.5a | 55.6 ± 6.9a | 2.2 | 0.27 | n/a |
Lee et al. [57] Pre-post intervention study | Low | Dynamic balance | Medio-lateral center of gravity displacement index score as a response to a moving platform | 3.4 ± 1.0 | 1.5 ± 0.8 | −1.9 | 1.98NR | n/a | n/a | n/a | n/a | n/a |
Ma et al. [61] Pre-post intervention study | Low | Dynamic balance | YBT composite reach distance (% leg length) | 97.0d ± 7.5a,d | 96.0d ± 7.5a,d | −1.0 | −0.13 | n/a | n/a | n/a | n/a | n/a |
Kim et al. [59] Pre-post intervention study | Low | Dynamic balance | YBT composite reach distance (% leg length) | 74.3 ± 8.3 | 82.4 ± 7.4 | 8.1 | 0.97* | n/a | n/a | n/a | n/a | n/a |
Pisal et al. [60] Pre-post intervention study | Low | Dynamic balance | YBT reach distance of right leg in posterolateral direction | 61.1 ± 5.2 | 65.1 ± 5.1 | 4.0 | 0.78* | n/a | n/a | n/a | n/a | n/a |